Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 467 Lymphoma 380 Precursor Cell Lymphoblastic Leukemia-Lymphoma 351 Leukemia 304 Lymphoma, Large B-Cell, Diffuse 303 Multiple Myeloma 288 Lymphoma, Non-Hodgkin 275 Leukemia, Lymphocytic, Chronic, B-Cell 251 Leukemia, Myeloid, Acute 245 Lymphoma, Follicular 210 Burkitt Lymphoma 190 Myelodysplastic Syndromes 185 Lymphoma, Mantle-Cell 173 Hodgkin Disease 172 Recurrence 133 Lymphoma, B-Cell, Marginal Zone 124 Melanoma 117 Lymphoma, Large-Cell, Immunoblastic 105 Neoplasms 93 Lymphoma, B-Cell 87 Neoplasms, Plasma Cell 86 Ovarian Neoplasms 81 Neuroblastoma 81 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 77 Hematologic Neoplasms 75 Myeloproliferative Disorders 74 Triple Negative Breast Neoplasms 73 Leukemia, Myeloid, Chronic-Phase 73 Dendritic Cell Sarcoma, Interdigitating 72 Leukemia, Myeloid, Accelerated Phase 71

Interventions

Fulvestrant 16 Letrozole 8 Anastrozole 7 Capecitabine 5 olaparib 4 Docetaxel 4 pyrotinib 3 palbociclib 3 Vinorelbine 3 Goserelin 3 Aromatase Inhibitors 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 exemestane 2 dalpiciclib 2 Trastuzumab 2 Paclitaxel 2 FCN-437c 2 Dasatinib 2 Alpelisib 2 vandetanib 1 talazoparib 1 sonidegib 1 neratinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 eribulin 1 entinostat 1 elacestrant 1 disitamab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04304352 2023-06-28

VEX

European Institute of Oncology

Phase 2 Unknown

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡